These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32408391)

  • 1. Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients.
    Menezes-Rodrigues FS; Padrão Tavares JG; Pires de Oliveira M; Guzella de Carvalho R; Ruggero Errante P; Omar Taha M; José Fagundes D; Caricati-Neto A
    J Thromb Haemost; 2020 Aug; 18(8):2073-2075. PubMed ID: 32408391
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care.
    Thomas W; White D; Cox-Morton S; MacDonald S; Besser M
    Thromb Res; 2020 Nov; 195():226-227. PubMed ID: 32795720
    [No Abstract]   [Full Text] [Related]  

  • 3. The versatile heparin in COVID-19.
    Thachil J
    J Thromb Haemost; 2020 May; 18(5):1020-1022. PubMed ID: 32239799
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential of heparin and nafamostat combination therapy for COVID-19.
    Asakura H; Ogawa H
    J Thromb Haemost; 2020 Jun; 18(6):1521-1522. PubMed ID: 32302456
    [No Abstract]   [Full Text] [Related]  

  • 5. Differentiating biochemical from clinical heparin resistance in COVID-19.
    Lisman T; Thachil J
    J Thromb Thrombolysis; 2020 Nov; 50(4):1015-1016. PubMed ID: 32880796
    [No Abstract]   [Full Text] [Related]  

  • 6. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.
    Canonico ME; Siciliano R; Scudiero F; Sanna GD; Parodi G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):262-264. PubMed ID: 32383737
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary embolism in patients with COVID-19 and its treatment based on low-molecular-weight heparin.
    Hosseini A; Bahramnezhad F
    Sao Paulo Med J; 2020; 138(4):349-351. PubMed ID: 32813845
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
    Cattaneo M; Bertinato EM; Birocchi S; Brizio C; Malavolta D; Manzoni M; Muscarella G; Orlandi M
    Thromb Haemost; 2020 Aug; 120(8):1230-1232. PubMed ID: 32349132
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.
    Conzelmann C; Müller JA; Perkhofer L; Sparrer KM; Zelikin AN; Münch J; Kleger A
    Clin Med (Lond); 2020 Nov; 20(6):e218-e221. PubMed ID: 32863274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients.
    Testa S; Paoletti O; Giorgi-Pierfranceschi M; Pan A
    Intern Emerg Med; 2020 Aug; 15(5):751-753. PubMed ID: 32297089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis.
    Perna AF; Capolongo G; Trepiccione F; Simeoni M; Zacchia M; Ingrosso D
    Kidney Blood Press Res; 2020; 45(3):357-362. PubMed ID: 32450560
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy".
    Coto-Hernández R; Fábregas Ruano MT
    J Thromb Haemost; 2020 Jun; 18(6):1519-1520. PubMed ID: 32302445
    [No Abstract]   [Full Text] [Related]  

  • 13. Type and dose of heparin in Covid-19: Reply.
    Thachil J; Tang N; Gando S; Falanga A; Levi M; Clark C; Iba T; Cattaneo M
    J Thromb Haemost; 2020 Aug; 18(8):2063-2064. PubMed ID: 32329221
    [No Abstract]   [Full Text] [Related]  

  • 14. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D-Dimer.
    Demirbaş A; Elmas ÖF; Türsen Ü; Atasoy M; Lotti T
    Dermatol Ther; 2020 Jul; 33(4):e13768. PubMed ID: 32500589
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'.
    Tang N
    J Thromb Haemost; 2020 Jun; 18(6):1520-1521. PubMed ID: 32302451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
    Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
    Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients.
    Aghamohammadi M; Alizargar J; Hsieh NC; Wu SV
    J Formos Med Assoc; 2020 Jul; 119(7):1230-1231. PubMed ID: 32402522
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?
    Buioni D; Nardi P; Ruvolo G
    Clin Chim Acta; 2020 Sep; 508():109. PubMed ID: 32417209
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
    Dragonetti D; Guarini G; Pizzuti M
    Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.